A report recently released in Mexico City by Mental Disability Rights International documents the appalling conditions in Mexico’s mental health system and makes recommendations for bringing the system into conformity with international human rights conventions.
February 28, 2000
February 24, 2000
The seventh annual Women’s Health 2000 conference at UC San Francisco looks beyond health to include a range of topics important to women. UCSF experts and guest speakers at the event will discuss how to develop negotiation skills, overcome gender expectations, assess unhealthy risk behaviors and get the most out of sex Women’s Health 2000 will take place from 8:30 am to 4:30 pm, Saturday, March 18, at UCSF, 513 Parnassus Ave.
February 23, 2000
First health forum of its kind gathered powerful group of academic, corporate and world health leaders to define action steps for creating global markets for drugs and vaccines
February 18, 2000
WASHINGTON, DC—In the early stages of fetal development, a nudge in the wrong direction can lead to irreparable birth defects, such as major brain and facial deformations. New research from the University of California, San Francisco shows that a brief deprivation of vitamin A in the heads of developing chickens can generate these severe craniofacial deformities, and that dosing the chicken embryo with a regulatory protein can restore a near normal face. The results suggest that, someday, carefully timed protein
February 17, 2000
The first mouse model genetically programmed to simulate motor deficits and brain alterations found in Parkinson’s disease and related disorders has been developed by a team of scientists at the University of California, San Diego; the University of California, San Francisco, and the Gladstone Institute of Neurological Disease. The research was led by Eliezer Masliah, M.D., of the UCSD Departments of Neurosciences and Pathology.
February 15, 2000
UCSF prevention scientists are looking for HIV-positive men to participate in a new research study aimed at reducing sexual behaviors that can lead to HIV transmission. Called “Bay Men,” the study is sponsored by the UCSF Center for AIDS Prevention Studies (CAPS). It will focus on decreasing isolation of HIV-positive men and engaging them in primary prevention of HIV. The project is funded by a three-year grant from the Centers for Disease Control and Prevention.
February 15, 2000
UC San Francisco researchers have found a strong genetic link between early stage, non-invasive breast cancer cells and recurrences of the disease after the initial tumors have been removed. The finding provides evidence that second tumors are caused by residual cells left over from the primary lesion and are not new, separate lesions, the researchers said.
February 10, 2000
When Nancy Pedder found it difficult to breathe when she swam, she had no idea that she was having heart failure. After all, she had just finished chemotherapy a few weeks earlier for breast cancer. Pedder soon became the first woman, and third person, to receive a heart transplant at UCSF. This Saturday, she will celebrate her second heart by going back to the people who made it possible 11 years ago.
February 07, 2000
Leaders from governments, biotechnology companies, and multi-lateral agencies from around the world will gather in Carmel Valley, CA, February 18-21 to study how best to promote development of drugs and vaccines for the world’s poorest countries. This Global Health Forum: “Creating Global Markets for Orphan Drugs & Vaccines: A Challenge for Public/Private Partnership,” will be sponsored by the Institute for Global Health, of the University of California, San Francisco, and UC Berkeley.
February 01, 2000
A $1 million grant has been awarded by the Universitywide AIDS Research Program of the University of California to conduct the first pilot study on liver and kidney transplantation in persons with HIV infection. The funds have been awarded to the University of California, San Francisco, to study the safety, efficacy and long-term benefits of the transplant procedures in up to seven HIV- infected patients receiving treatment at UC San Francisco.